2013-10-16 13:39:44 UTC

AGA Welcomes the Renaissance of IBS Patient Care

Strides in Research Made Possible by Funding from the AGA Research Foundation

Bethesda, MD (Oct. 16, 2013) — The American Gastroenterological Association (AGA) Research Foundation has released the second video in “The Stories Behind the Science” video series. Michael Camilleri, MD, AGAF, of the Mayo Clinic, brings viewers inside a Mayo Clinic laboratory to discuss this exciting renaissance period for irritable bowel syndrome (IBS). Watch the video.

“There is a critical need to develop new, noninvasive methods to evaluate the functions of the stomach, intestines and the colon to improve the diagnosis and treatment of IBS,” said Dr. Camilleri, Atherton & Winifred W. Bean Professor of Medicine, Pharmacology & Physiology, Mayo Clinic College of Medicine, Rochester, MN. “With funding from the AGA Research Foundation, we have developed new tools to aid in the treatment of IBS, and we are one step closer to personalizing IBS patient care.”

Dr. Camilleri and his team of investigators received funding from the AGA Research Foundation in 1992, early in Dr. Camilleri’s research career. Since that initial funding, Dr. Camilleri’s team developed and validated a noninvasive transit measurement, which allows physicians to assess how fast or slow content moves through the colon. This innovation has led to a 100 percent success rate (12 of 12) for predicting the effectiveness of IBS medication prior to use in a clinical trial; the approved drugs are: Lotronex, Zelnorm, Amitiza, Linzess and Resolor. Dr. Camilleri is now conducting a study to identify the individual factor that may be responsible for patient symptoms. This discovery will allow physicians to personalize IBS treatment.

“In order to advance the field of gastroenterology and improve the quality of life for patients suffering from digestive diseases, research funding is essential,” said Dr. Camilleri, who is also vice president of the AGA. “Support from the AGA Research Foundation has helped to transform the current research landscape, and future investments will enable young investigators to continue this renaissance.”

The AGA Research Foundation serves the physicians and scientists who research, diagnose, prevent and treat diseases of the gastrointestinal tract and liver and serves the patients who depend on AGA’s members. This year, the foundation will award more than $2 million in gastroenterology and hepatology research grants. Learn more on our website, www.gastro.org/foundation.

Watch part one of the “Stories Behind the Science” video series, which highlights a monumental discovery in colon cancer genetics.

For more information on IBS, please read the AGA brochure “A Patient's Guide to Living with Irritable Bowel Syndrome.”

# # #

About the AGA Research Foundation

The AGA Research Foundation, formerly known as the Foundation for Digestive Health and Nutrition, is the cornerstone of AGA’s effort to expand digestive disease research funding. Since 1984, the AGA, through its foundations, has provided more than $40 million in research grants to more than 770 scientists. The AGA Research Foundation serves as a bridge to the future of research in gastroenterology and hepatology by providing critical funding to advance the careers of young researchers between the end of training and the establishment of credentials that earn National Institutes of Health grants. Learn more about the AGA Research Foundation or make a contribution at www.gastro.org/foundation.

About the AGA Institute

The American Gastroenterological Association is the trusted voice of the GI community. Founded in 1897, the AGA has grown to include 17,000 members from around the globe who are involved in all aspects of the science, practice and advancement of gastroenterology. The AGA Institute administers the practice, research and educational programs of the organization. www.gastro.org

Follow us on Twitter @AmerGastroAssn.
Become an AGA fan on Facebook.
Join AGA on LinkedIn.
Check out our videos on YouTube.